- Generic name
- Atorvastatin + Ezetimibe
- Strength
- 20 mg + 10 mg
- Dosage form
- Tablet
- Manufactured by
- Delta Pharma Limited
ATV Eze 20 Tablet
About ATV Eze 20 20 mg + 10 mg Tablet
ATV Eze 20 20 mg + 10 mg is a tablet product of Delta Pharma Limited that contains Atorvastatin + Ezetimibe. It is not a standalone treatment; it should be combined with multiple risk factor interventions.
There are 8 brands of Atorvastatin + Ezetimibe listed in Bangladesh.
What is ATV Eze 20 20 mg + 10 mg Tablet?
Made by Delta Pharma Limited, ATV Eze 20 is a tablet whose active ingredient is Atorvastatin + Ezetimibe. This medicine is used as part of a wider plan to reduce the risk of heart and blood vessel problems linked to high cholesterol. Atorvastatin reduces cholesterol production in the liver, while ezetimibe reduces cholesterol absorption from the intestine. Ask your doctor or pharmacist if you are unsure about it.
Uses of ATV Eze 20
It is not a standalone treatment; it should be combined with multiple risk factor interventions. The combination helps reduce LDL cholesterol and other fats in the blood. It is prescribed alongside a cholesterol-lowering diet and other lifestyle measures. Your doctor will decide if it is suitable for you.
How to use ATV Eze 20
The tablet is usually taken by mouth, but the exact schedule depends on the prescription. Swallow the tablet with water. Follow your doctor's instructions carefully. Complete the course exactly as prescribed. Do not change the dose or stop early without asking your doctor.
Side effects of ATV Eze 20
Like all medicines, ATV Eze 20 can cause side effects, although not everyone gets them. Patients should promptly report any unexplained or persistent muscle pain, tenderness, or weakness to the doctor, as these may be signs of muscle problems. Some people may experience headache, stomach upset, muscle pain, or tiredness. Tell your doctor promptly if you notice unexplained or persistent muscle pain, tenderness, or weakness, as this can be a sign of a rare but serious muscle problem. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
It is contraindicated during pregnancy and breastfeeding. Report any muscle symptoms promptly. Your doctor may adjust your dose or monitor you more closely. Keep out of reach of children.
Frequently asked questions
Why is ATV Eze 20 prescribed?
It is not a standalone treatment; it should be combined with multiple risk factor interventions. The combination helps reduce LDL cholesterol and other fats in the blood.
How do I use ATV Eze 20 correctly?
The tablet is usually taken by mouth, but the exact schedule depends on the prescription. Swallow the tablet with water.
What should I watch for while using ATV Eze 20?
Like all medicines, ATV Eze 20 can cause side effects, although not everyone gets them. Patients should promptly report any unexplained or persistent muscle pain, tenderness, or weakness to the doctor, as these may be signs of muscle problems.
Is ATV Eze 20 safe for everyone?
It is contraindicated during pregnancy and breastfeeding. Report any muscle symptoms promptly.
Indications
Primary Hyperlipidemia: This tablet is indicated for the reduction of elevated total cholesterol (total-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and non-high-density lipoprotein cholesterol (non-HDL-C), and to increase high-density lipoprotein cholesterol (HDL-C) in patients with primary (heterozygous familial and non-familial) hyperlipidemia or mixed hyperlipidemia.
Homozygous Familial Hypercholesterolemia (HoFH): This tablet is indicated for the reduction of elevated total-C and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to other lipid lowering treatments (e.g., LDL apheresis) or if such treatments are unavailable.
Pharmacology
Ezetimibe: Ezetimibe reduces blood cholesterol by inhibiting the absorption of cholesterol by the small intestine. The molecular target of ezetimibe has been shown to be the sterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), which is involved in the intestinal uptake of cholesterol and phytosterols. In a 2-week clinical study in 18 hypercholesterolemic patients, ezetimibe inhibited intestinal cholesterol absorption by 54%, compared with placebo. Ezetimibe had no clinically meaningful effect on the plasma concentrations of the fat-soluble vitamins A, D, and E and did not impair adrenocortical steroid hormone production. Ezetimibe does not inhibit cholesterol synthesis in the liver or increase bile acid excretion. Ezetimibe localizes at the brush border of the small intestine and inhibits the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver. This causes a reduction of hepatic cholesterol stores and an increase in clearance of cholesterol from the blood; this distinct mechanism is complementary to that of statins.
Dosage & Administration
Interaction
- Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir), gemfibrozil: Avoid this tablet
- HIV protease inhibitor (lopinavir plus ritonavir): Use with caution and lowest dose necessary.
- Clarithromycin, itraconazole, HIV protease inhibitors (saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir): Do not exceed 10/20 mg this tablet daily.
- HIV protease inhibitor (nelfinavir), hepatitis C protease inhibitor (boceprevir): Do not exceed 10/40 mg this tablet daily.
- Other lipid-lowering medications: Use with fenofibrates or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. Caution should be used when prescribing with this tablet.
- Fenofibrates: Combination increases exposure of ezetimibe. If cholelithiasis is suspected in a patient receiving ezetimibe and a fenofibrate, gallbladder studies are indicated and alternative lipid- lowering therapy should be considered.
- Cholestyramine: Combination decreases exposure of ezetimibe.
- Digoxin: Patients should be monitored appropriately.
- Oral contraceptives: Values for norethindrone and ethinyl estradiol may be increased.
- Rifampin should be simultaneously coadministered with this tablet.
Contraindications
- Active liver disease or unexplained persistent elevations of hepatic transaminase levels.
- Hypersensitivity to any component of this tablet.
- Women who are pregnant or may become pregnant.
- Nursing mothers.
Pregnancy & Lactation
Precautions & Warnings
Skeletal muscle effects (e.g., myopathy and rhabdomyolysis): Risks increase with higher doses and concomitant use of certain CYP3A4 inhibitors, fibric acid derivatives, and cyclosporine. Predisposing factors include advanced age (>65), uncontrolled hypothyroidism, and renal impairment. Rare cases of rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported.
Liver enzyme abnormalities: Persistent elevations in hepatic transaminase can occur. Check liver enzyme tests before initiating therapy and as clinically indicated thereafter.
Storage Conditions
Alternative brands of Atorvastatin + Ezetimibe
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.